Both platforms offer alternatives to GLP-1 injections, including oral medication kits and multiple medication formats for those who prefer non-injectable options
When consumers stop a GLP-1 drug, the health benefits experienced are often eroded: a preliminary study showed that those who stopped taking GLP-1 prescriptions on average gained two thirds of lost weight back, diminishing the health benefits of the drugs over time
doi:10.1016/s0140-6736(19)31149-3 Davies MJ, Bergenstal R, Bode B, Kushner RF, Lewin A, Skjth TV, et al
The most striking observation from community reports is what is not present: accounts of cancer development following BPC-157 use
A 2016 study noted its impact on reducing gut inflammation and protecting against ulcers
Although essential for maintaining intestinal homeostasis, dysregulated inflammasome activity is a key driver in the pathogenesis of chronic IBD